Bernstein said Biocon Ltd and Mankind Ltd are its non-consensus 'Underperform' stock ideas. It called Aurobindo Pharma as ...

Biocon founder Kiran Mazumdar-Shaw has named her MIT- and Stanford-trained niece, Claire Mazumdar, as successor, marking a pivotal leadership transition for India’s biotech giant. Discover how Shaw ...

Biocon already has a wide pipeline of biosim molecules and partnerships with global drugmakers. Now, it’s picked up a 60,000-square-foot R&D site from Pfizer to advance on its ambitions in biosimilars ...

Biocon's transformative journey under Kiran Mazumdar-Shaw highlights a significant succession plan and corporate ...

Shares of Indian drugmaker Biocon Ltd fell about 12% on Monday after the company said its unit Biocon Biologics would buy U.S.-based Viatris Inc's biosimilars business in a transaction valued at $3.34 ...

Other pharma stocks, including Wockhardt Ltd, Lupin Ltd, Divi's Laboratories Ltd, Zydus Lifesciences Ltd, Torrent ...

Novozymes Buys Enzyme Business of BIOCON Pharmaceuticals in India for $102 Million FRANKLINTON, N.C. -- Novozymes has today signed a definitive agreement under which it will acquire the enzyme ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: India's Biocon Ltd Chairman and Managing Director Kiran Mazumdar-Shaw speaks during the Forbes Global CEO Conference ...

BENGALURU, Dec 9 (Reuters) - Indian drugmaker Biocon Ltd BION.NS is in talks with generic drugmaker Mylan for a merger of their biosimilar businesses,financial newswebsite Moneycontrol reported on ...